Retraction to: Cannabinoid CB 2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide : CB 2 receptor signalling in microglia (British Journal of Pharmacology, (2012), 165, 6, (1773-1788), 10.1111/j.1476-5381.2011.01673.x);Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

British Journal of Pharmacology

Volumn 165, Issue 6, 2012, Pages 1773-1788

  Merighi, Stefania ^a   Gessi, Stefania ^a   Varani, Katia ^a   Simioni, Carolina ^a   Fazzi, Debora ^a   Mirandola, Prisco ^b   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

cannabinoids; ERK 1 2; microglia; NO; signalling pathways

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; BACTERIUM LIPOPOLYSACCHARIDE; CANNABINOID 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MICROGLIA; MOUSE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 84857514914     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13915     Document Type: Erratum

References (56)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Aloisi F, (2001). Immune function of microglia. Glia 36: 165-179.
3. 2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160: 467-479.
4. 2 receptors in human brain inflammation. Br J Pharmacol 153: 277-285.
5. Bhat NR, Zhang P, Lee JC, Hogan EL, (1998). Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18: 1633-1641.
6. Bodles AM, Barger SW, (2005). Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol Aging 26: 9-16.
7. Bosier B, Muccioli GG, Hermans E, Lambert DM, (2010). Functionally selective cannabinoid receptor signaling: therapeutic implications and opportunities. Biochem Pharmacol 80: 1-12.
8. 2 receptors in the brain: role in central immune function. Br J Pharmacol 153: 240-251.
9. Corradin SB, Mauel J, Donini SD, Quattrocchi E, Castagnoli PR, (1993). Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 7: 255-262.
10. 2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br J Pharmacol 145: 441-448.
11. Correa F, Docagne F, Clemente D, Mestre L, Becker C, Guaza C, (2008). Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). Biochem J 409: 761-770.
12. 2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol 77: 86-100.
13. 2 receptors: roles of ERK1/2, JNK, and NF-kappaB. Glia 58: 135-147.
14. Correa F, Hernangõmez-Herrero M, Mestre L, Loría F, Docagne F, Guaza C, (2011). The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells. Brain Behav Immun 25: 736-749.
15. 2) suppresses microglial activation. J Neuroinflammation 2: 29.
16. Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, et al,. (2006). The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49: 67-79.
17. Fachinetti F, Del Giudice G, Furegato S, Passarotto M, Leon M, (2003). Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide. Glia 41: 161-168.
18. Fernández-Ruiz J, (2009). The endocannabinoid system as a target for the treatment of motor dysfunction. Br J Pharmacol 156: 1029-1040.
19. 2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28: 39-45.
20. Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, et al,. (2008). Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105: 9099-9104.
21. Gobbi G, Mirandola P, Tazzari PL, Ricci F, Caimi L, Cacchioli A, et al,. (2003). Flow cytometry detection of serotonin content and release in resting and activated platelets. Br J Haematol 121: 892-896.
22. González-Scarano F, Baltuch G, (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219-240.
23. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR, (1982). Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126: 131-138.
24. Hanisch UK, Kettenmann H, (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
25. 1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. FEBS Lett 459: 277-281.
26. Horvath RJ, Nutile-McMenemy N, Alkaitis MS, Deleo JA, (2008). Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J Neurochem 107: 557-569.
27. Howlett AC, (2005). Cannabinoid receptor signaling. Handb Exp Pharmacol 168: 53-79.
28. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al,. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
29. Hsieh GC, Pai M, Chandran P, Hooker BA, Zhu CZ, Salyers AK, et al,. (2011). Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br J Pharmacol 162: 428-440.
30. Jeon YJ, Yang KH, Pulaski JT, Kaminsky ND, (1996). Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation. Mol Pharmacol 50: 334-341.
31. Jung WK, Lee DY, Park C, Choi YH, Choi I, Park SG, et al,. (2010). Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases. Br J Pharmacol 159: 1274-1285.
32. 2 receptor. Br J Pharmacol 139: 775-786.
33. Klein TW, Newton CA, (2007). Therapeutic potential of cannabinoid-based drugs. Adv Exp Med Biol 601: 395-413.
34. Kreitzer FR, Stella N, (2009). The therapeutic potential of novel cannabinoid receptors. Pharmacol Ther 122: 83-96.
35. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al,. (2002). The toll-like receptor TLR4 is necessary for lipopolysaccharide- induced oligodendrocyte injury in the CNS. J Neurosci 22: 2478-2486.
36. Lourbopoulos A, Grigoriadis N, Lagoudaki R, Touloumi O, Polyzoidou E, Mavromatis I, et al,. (2011). Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. Brain Res 1390: 126-141.
37. Marrs WR, Blankman JL, Horne EA, Thomazeau A, Lin YH, Coy J, et al,. (2010). The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci 13: 951-957.
38. 3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 280: 19516-19526.
39. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, et al,. (2007). Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 72: 395-406.
40. 3 adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. Neoplasia 11: 1064-1073.
41. 2 receptors. Biochem Pharmacol 79: 471-477.
42. 2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J Neurosci Res 67: 829-836.
43. 2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. J Neuroimmunol 181: 82-92.
44. Murphy S, (2000). Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29: 1-13.
45. Oh YT, Lee JY, Lee J, Lee JH, Kim JE, Ha J, et al,. (2010). Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells. Neurosci Lett 474: 148-153.
46. Ortega-Gutiérrez S, Molina-Holgado E, Guaza C, (2005). Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia 52: 163-168.
47. 2. Pharmacol Rev 62: 588-631.
48. Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, et al,. (2009). Differential changes in GPR55 during microglial cell activation. FEBS Lett 583: 2071-2076.
49. Romero-Sandoval EA, Horvath R, Landry RP, DeLeo, JA, (2009). Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation. Mol Pain 5: 25.
50. Ross RA, Brockie HC, Pertwee RG, (2000). Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur J Pharmacol 401: 121-130.
51. Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK, (2005). Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia 49: 211-219.
52. Stefano GB, Liu Y, Goligorsky MS, (1996). Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 271: 19238-19242.
53. Stella N, (2010). Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58: 1017-1030.
54. 1 mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 288: 357-366.
55. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, et al,. (2003). Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23: 1398-1405.
56. Wang MJ, Kuo JS, Lee WW, Huang HY, Chen WF, Lin SZ, (2006). Translational event mediates differential production of tumor necrosis factor-alpha in hyaluronan-stimulated microglia and macrophages. J Neurochem 97: 857-871.